Health
An existing drug may function as targeted therapy for ALL in children – News-Medical.Net
A new study from Linköping University has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases…
A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by treatment with an existing…
Continue Reading
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News20 hours agoSudden death investigation, Maroochydore – Sunshine Coast